Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
Express Scripts
Mallinckrodt
Dow
AstraZeneca

Last Updated: October 22, 2019

DrugPatentWatch Database Preview

Claims for Patent: 10,292,990

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,292,990
Title:Abiraterone steroid formulation
Abstract: A nanoparticulate composition of abiraterone acetate that allows treatment at a lower dose than convention abiraterone acetate formulations is described as in a method of treating prostate cancer by administering the composition together with a glucocorticoid.
Inventor(s): Nemeth; Paul (Philadelphia, PA), Callahan; Matt (Penn Valley, PA), Bosch; H. William (Bryn Mawr, PA), Norret; Marck (Darlington, AU)
Assignee: SUN PHARMA GLOBAL FZE (Sharjah, AE)
Application Number:15/345,410
Patent Claims: 1. A method of treating prostate cancer comprising administering methylprednisolone and a daily dose of between 400 and 600 mg of abiraterone acetate, wherein the abiraterone acetate is in the form of a tablet or a capsule and has a median particle size of 100 nm to 1000 nm on a volume average basis.

2. The method of claim 1 wherein the daily dose of abiraterone acetate is administered as a single dose.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
McKinsey
Merck
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.